Bausch+Lomb IPO Presentation Deck
An integrated approach to innovation
Research & Development
>260
New Products introduced in
~60 countries since 2017
BAUSCH + LOMB
>100
projects in various stages of
pre-clinical and clinical
development in the pipeline
-$1.0B
R&D (2018-2021)
~850 dedicated
R&D employees
engineers, scientists &
other specialized personnel
principally located at 24
sites in 10 countries
G
PIPELINE
Product Development Approach
Culture of innovation engages R&D, supply chain and
commercial teams at every phase of product development
Cross-functional expertise of R&D, quality, clinical,
medical & regulatory affairs, supply chain & commercial
representatives throughout development
Significant number of recently launched products and robust
pipeline of products at various stages of development across
business from early concept to late-stage development
Prioritize and address the changing needs of our
consumers and patients, leveraging deep relationships
with physicians and optometrists
Long history of being a leader in the eye health market with
ground-breaking innovations
34View entire presentation